Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2017

Aug 4, 2017

32414_dirs_2017-08-04_f11d57b0-e32f-4b77-9499-00a71fca8297.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-08-02

Reporting Person: MCCARREY SHAWN F (SVP Sales)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-02 Common Stock A 7150 Acquired 41550 Direct
2017-08-02 Common Stock F 2383 $15.15 Disposed 39167 Direct

Footnotes

F1: Represents shares of common stock that have vested and settled in accordance with that certain PSU Agreement granted to the reporting person on December 29, 2016.